{
    "2018-12-17": [
        [
            {
                "time": "",
                "original_text": "公告精选：多家银行再融资申请获通过；金陵体育实控人提议高送转",
                "features": {
                    "keywords": [
                        "银行",
                        "再融资",
                        "金陵体育",
                        "高送转"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融",
                        "体育"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "安图生物：增资Mobidiag暨设合资公司 完善分子诊断领域布局",
                "features": {
                    "keywords": [
                        "安图生物",
                        "增资",
                        "合资公司",
                        "分子诊断"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "安图生物：免疫诊断龙头 流水线驱动下一轮加速发展",
                "features": {
                    "keywords": [
                        "安图生物",
                        "免疫诊断",
                        "流水线",
                        "加速发展"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2019年年度投资策略报告:继续看好创新药企及细分领域龙头企业的发展",
                "features": {
                    "keywords": [
                        "医药行业",
                        "投资策略",
                        "创新药企",
                        "细分领域",
                        "龙头企业"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}